| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.097 | 0.04 |